Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Oncology Nursing Forum|July 1, 1989
Continuous infusion chemotherapy in the ambulatory setting: the nurse's role in patient selection and educationB Reville, L AlmadronesOncology Nursing Forum|January 1, 1990
Problems associated with the administration of intraperitoneal therapy using the Port-A-Cath systemL Almadrones, C YerysSeminars in Oncology Nursing|August 1, 1995
Arterial, peritoneal, and intraventricular access devicesL Almadrones, P Campana, E C DantisGynecologic Oncology|May 8, 1998
Palliative benefit of external-beam radiation in the management of platinum refractory epithelial ovarian carcinomaD Gelblum, B Mychalczak, L Almadrones, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Follow-up of Memorial Sloan-Kettering Cancer Center patients treated on National Cancer Institute Treatment Referral Center protocol 9103: paclitaxel in refractory ovarian cancerM Markman, T Hakes, R Barakat, et al.American Journal of Obstetrics and Gynecology|January 1, 1993
Prognostic significance of HER-2/neu expression in advanced epithelial ovarian cancer: a multivariate analysisS C Rubin, C L Finstad, G Y Wong, et al.Obstetrics and Gynecology|June 1, 1993
Relationship between saliva and serum CA 125 in women with and without epithelial ovarian cancerM Plante, G Y Wong, J S Nisselbaum, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 1991
Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatinM Markman, B Reichman, T Hakes, et al.Gynecologic Oncology|April 1, 1996
The impact of diabetes mellitus on the toxicity of therapy for advanced ovarian cancerH Gogas, F Shapiro, C Aghajanian, et al.Gynecologic Oncology|March 30, 2001
Complications associated with intraperitoneal chemotherapy cathetersS Makhija, M Leitao, P Sabbatini, et al.Pageof 5